Multicenter study demonstrates specific characteristics of moyamoya disease in young children, indicating unique clinical implications.
This study demonstrated that demographic, clinical, and radiological characteristics are very specific in patients with moyamoya disease under 4 years of age, especially those under 1 year. Even a very early disease stage (Suzuki stage 2) could provoke TIA and/or ischemic stroke through the mechanism of artery-to-artery embolism as well as hemodynamic ischemia. Clinical trial registration no.: UMIN000040169 (www.umin.ac.jp).
No takes yet. Share an insight, caveat, or question.
Kuroda et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: